Cetera Advisor Networks LLC Alaunos Therapeutics, Inc. Transaction History

Cetera Advisor Networks LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.5 $95 - $398	797 Added 6.45%	13,157 $1,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $486 - $856	-1,058 Reduced 7.88%	12,360 $7,000
Q2 2022 Aug 11, 2022	BUY	$0.41 - $1.24 $5,501 - $16,638	13,418 New	13,418 $17,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $18,642 - $26,754	-7,800 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $17,160 - $28,938	7,800 New	7,800 $26,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.